Clinical Trial Update: Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the safety and efficacy of HGP1207 in patients with pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Systolic Dysfunction

Drugs mentioned

• HGP1207

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Pulmonary Hypertension, Systolic Dysfunction | Phase 3 | Status: UNKNOWN